Editorial Archives - Page 12 of 123 - ExecEdge

On Running Sees Record Q1 Net Sales on Asian Demand

On Running Sees Record Q1 Net Sales on Asian Demand

  By Daniella Parra On Running (NYSE: ONON) said first quarter net sales increased by 14.5% from a year earlier, reaching CHF 831.9 million. The company said sales in the Asia-Pacific region grew 44.4%, representing more than 20% of global...

Corpay Earnings Demonstrate Shift to Long-Term Compounder

Corpay Earnings Demonstrate Shift to Long-Term Compounder

By Jarrett Banks Corpay, Inc. (NYSE: CPAY) delivered the kind of quarter that shifts the narrative from a solid payments company to a potential long-term compounder. Across Wall Street brokerage reports, the themes were the same: accelerating Corporate Payments momentum,...

Glucotrack Submits Blood Glucose Monitoring Technology to FDA

Glucotrack Submits Blood Glucose Monitoring Technology to FDA

By Daniella Parra Glucotrack, Inc. (Nasdaq: GCTK) said it has submitted an Investigational Device Exemption application to the FDA to begin a U.S. clinical study for its fully implantable continuous blood glucose monitoring technology. The company said it is designed...

Input your search keywords and press Enter.